BRPI0620863A8 - comprimido em camadas com combinação de liberação tripla - Google Patents
comprimido em camadas com combinação de liberação triplaInfo
- Publication number
- BRPI0620863A8 BRPI0620863A8 BRPI0620863A BRPI0620863A BRPI0620863A8 BR PI0620863 A8 BRPI0620863 A8 BR PI0620863A8 BR PI0620863 A BRPI0620863 A BR PI0620863A BR PI0620863 A BRPI0620863 A BR PI0620863A BR PI0620863 A8 BRPI0620863 A8 BR PI0620863A8
- Authority
- BR
- Brazil
- Prior art keywords
- dosage form
- triple
- tablet
- layered tablet
- release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Abstract
comprimido em camadas com combinação de liberação tripla. a presente invenção refere-se a um comprimido em camadas para a tripla liberação de agentes ativos de forma combinada em um ambiente de uso. mais especificamente, a invenção diz respeito a um comprimido em camadas (1) contendo duas camadas externas contendo fármacos (2 e 3) sobrepostas a e em lados opostos de uma forma de dosagem oral (4) que disponibiliza, de forma combinada, a tripla liberação de pelo menos um agente ativo. em uma modalidade da invenção, a forma de dosagem é um dispositivo osmótico. em uma outra modalidade da invenção, a forma de dosagem a forma de dosagem é um núcleo revestido com material resistente ao suco gástrico. ainda em outra modalidade da invenção, a forma de dosagem é um comprimido matricial. em uma modalidade diversa a forma de dosagem é uma cápsula dura.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75497205P | 2005-12-29 | 2005-12-29 | |
US60/754,972 | 2005-12-29 | ||
PCT/CR2006/000008 WO2007073702A2 (es) | 2005-12-29 | 2006-12-20 | Comprimido multicapa con combinación de triple liberación |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0620863A2 BRPI0620863A2 (pt) | 2011-11-29 |
BRPI0620863A8 true BRPI0620863A8 (pt) | 2018-01-16 |
Family
ID=38218330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0620863A BRPI0620863A8 (pt) | 2005-12-29 | 2006-12-20 | comprimido em camadas com combinação de liberação tripla |
Country Status (8)
Country | Link |
---|---|
US (2) | US8685451B2 (pt) |
EP (1) | EP1970055B1 (pt) |
AR (1) | AR058604A1 (pt) |
AT (1) | ATE489079T1 (pt) |
BR (1) | BRPI0620863A8 (pt) |
CA (1) | CA2635313C (pt) |
DE (1) | DE602006018529D1 (pt) |
WO (1) | WO2007073702A2 (pt) |
Families Citing this family (112)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
US20070281003A1 (en) | 2001-10-12 | 2007-12-06 | Fuisz Richard C | Polymer-Based Films and Drug Delivery Systems Made Therefrom |
US20110033542A1 (en) | 2009-08-07 | 2011-02-10 | Monosol Rx, Llc | Sublingual and buccal film compositions |
US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
US7357891B2 (en) | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
US20190328679A1 (en) | 2001-10-12 | 2019-10-31 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
EP2671507A3 (en) * | 2005-04-28 | 2014-02-19 | Proteus Digital Health, Inc. | Pharma-informatics system |
US8802183B2 (en) | 2005-04-28 | 2014-08-12 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
US9198608B2 (en) | 2005-04-28 | 2015-12-01 | Proteus Digital Health, Inc. | Communication system incorporated in a container |
US8912908B2 (en) | 2005-04-28 | 2014-12-16 | Proteus Digital Health, Inc. | Communication system with remote activation |
US8836513B2 (en) | 2006-04-28 | 2014-09-16 | Proteus Digital Health, Inc. | Communication system incorporated in an ingestible product |
CA2611114C (en) * | 2005-06-08 | 2014-09-23 | Orion Corporation | An entacapone-containing oral dosage form |
CA2635313C (en) | 2005-12-29 | 2013-12-31 | Osmotica Corp. | Triple combination release multi-layered tablet |
NZ569984A (en) * | 2006-01-27 | 2011-06-30 | Eurand Inc | Drug delivery systems comprising weakly basic drugs and organic acids |
AU2007211091B8 (en) * | 2006-01-27 | 2013-08-29 | Adare Pharmaceuticals, Inc. | Drug delivery systems comprising weakly basic selective serotonin 5-HT3 blocking agent and organic acids |
JP2009544338A (ja) | 2006-05-02 | 2009-12-17 | プロテウス バイオメディカル インコーポレイテッド | 患者に合わせてカスタマイズした治療レジメン |
SG175681A1 (en) | 2006-10-25 | 2011-11-28 | Proteus Biomedical Inc | Controlled activation ingestible identifier |
WO2008053297A2 (en) * | 2006-10-30 | 2008-05-08 | Wockhardt Research Centre | Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa |
EP2069004A4 (en) | 2006-11-20 | 2014-07-09 | Proteus Digital Health Inc | PERSONAL HEALTH SIGNAL RECEIVERS WITH ACTIVE SIGNAL PROCESSING |
AU2008210291B2 (en) | 2007-02-01 | 2013-10-03 | Otsuka Pharmaceutical Co., Ltd. | Ingestible event marker systems |
MY154556A (en) | 2007-02-14 | 2015-06-30 | Proteus Digital Health Inc | In-body power source having high surface area electrode |
EP2063771A1 (en) | 2007-03-09 | 2009-06-03 | Proteus Biomedical, Inc. | In-body device having a deployable antenna |
US8932221B2 (en) | 2007-03-09 | 2015-01-13 | Proteus Digital Health, Inc. | In-body device having a multi-directional transmitter |
CN101652129B (zh) * | 2007-03-30 | 2012-07-04 | 琳得科株式会社 | 口服制剂及其制造方法 |
US8540632B2 (en) | 2007-05-24 | 2013-09-24 | Proteus Digital Health, Inc. | Low profile antenna for in body device |
EP2192946B1 (en) | 2007-09-25 | 2022-09-14 | Otsuka Pharmaceutical Co., Ltd. | In-body device with virtual dipole signal amplification |
AU2008329620B2 (en) | 2007-11-27 | 2014-05-08 | Otsuka Pharmaceutical Co., Ltd. | Transbody communication systems employing communication channels |
ES2636844T3 (es) | 2008-03-05 | 2017-10-09 | Proteus Biomedical, Inc. | Sistemas y marcadores de eventos ingeribles de comunicación multimodo, y métodos para usarlos |
EP2285219B1 (en) * | 2008-05-08 | 2018-07-18 | Supernus Pharmaceuticals, Inc. | Controlled release formulations of alprazolam |
US8969417B2 (en) * | 2008-06-06 | 2015-03-03 | Pharmatwob Ltd. | Pharmaceutical compositions for treatment of Parkinsons disease |
CA2730275C (en) | 2008-07-08 | 2019-05-21 | Proteus Biomedical, Inc. | Ingestible event marker data framework |
US8540633B2 (en) | 2008-08-13 | 2013-09-24 | Proteus Digital Health, Inc. | Identifier circuits for generating unique identifiable indicators and techniques for producing same |
CN102170870A (zh) * | 2008-08-22 | 2011-08-31 | 沃克哈特研究中心 | 恩他卡朋或其盐的缓释药物组合物 |
EP2326311B1 (en) * | 2008-08-22 | 2014-06-04 | Wockhardt Limited | Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof |
EP2452677A1 (en) * | 2008-09-29 | 2012-05-16 | Wockhardt Limited | Extended release dosage form of ropinirole |
KR20110075011A (ko) * | 2008-11-10 | 2011-07-05 | (주)아모레퍼시픽 | 서방성 미립자 및 이의 제조방법 |
US8055334B2 (en) | 2008-12-11 | 2011-11-08 | Proteus Biomedical, Inc. | Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same |
CA2750158A1 (en) | 2009-01-06 | 2010-07-15 | Proteus Biomedical, Inc. | Ingestion-related biofeedback and personalized medical therapy method and system |
KR20110104079A (ko) | 2009-01-06 | 2011-09-21 | 프로테우스 바이오메디컬, 인코포레이티드 | 약제학적 투여량 전달 시스템 |
GB2480965B (en) | 2009-03-25 | 2014-10-08 | Proteus Digital Health Inc | Probablistic pharmacokinetic and pharmacodynamic modeling |
SG10201810784SA (en) | 2009-04-28 | 2018-12-28 | Proteus Digital Health Inc | Highly Reliable Ingestible Event Markers And Methods For Using The Same |
EP2432458A4 (en) | 2009-05-12 | 2014-02-12 | Proteus Digital Health Inc | ACCEPTABLE EVENT MARKER WITH SUGAR COMPONENT |
US20110003005A1 (en) * | 2009-07-06 | 2011-01-06 | Gopi Venkatesh | Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions |
TWI517050B (zh) | 2009-11-04 | 2016-01-11 | 普羅托斯數位健康公司 | 供應鏈管理之系統 |
UA109424C2 (uk) | 2009-12-02 | 2015-08-25 | Фармацевтичний продукт, фармацевтична таблетка з електронним маркером і спосіб виготовлення фармацевтичної таблетки | |
WO2011075912A1 (zh) * | 2009-12-25 | 2011-06-30 | 台湾东洋药品工业股份有限公司 | 治疗帕金森氏症的医药组合物及其制备方法 |
CN102905672B (zh) | 2010-04-07 | 2016-08-17 | 普罗秋斯数字健康公司 | 微型可吞服装置 |
IT1399630B1 (it) * | 2010-04-20 | 2013-04-26 | Perfetti Van Melle Spa | Formulazioni alimentari a lento rilascio |
TWI557672B (zh) | 2010-05-19 | 2016-11-11 | 波提亞斯數位康健公司 | 用於從製造商跟蹤藥物直到患者之電腦系統及電腦實施之方法、用於確認將藥物給予患者的設備及方法、患者介面裝置 |
PE20170306A1 (es) * | 2010-06-16 | 2017-05-06 | Takeda Pharmaceuticals Usa Inc | Nuevas formas de dosificacion de liberacion modificada de un inhibidor de la xantina oxidorreductasa o de inhibidores de xantina oxidasa |
CN103124559B (zh) | 2010-08-04 | 2017-03-29 | 托马斯·朱利叶斯·波洛迪 | 用于粪便菌群植入的组合物及其制备和使用方法以及递送该组合物的装置 |
US9149959B2 (en) | 2010-10-22 | 2015-10-06 | Monosol Rx, Llc | Manufacturing of small film strips |
EP2642983A4 (en) | 2010-11-22 | 2014-03-12 | Proteus Digital Health Inc | DEVICE INGREABLE WITH PHARMACEUTICAL PRODUCT |
CN110200954A (zh) | 2010-12-13 | 2019-09-06 | 萨利克斯药品有限公司 | 胃和结肠的配制剂及其制备和使用方法 |
US9326946B2 (en) * | 2011-03-03 | 2016-05-03 | Takeda Pharmaceutical Company Limited | Laminated tablet and manufacturing method therefor |
AU2012225305B2 (en) | 2011-03-09 | 2017-06-08 | Regents Of The University Of Minnesota | Compositions and methods for transplantation of colon microbiota |
US11129799B2 (en) | 2011-04-12 | 2021-09-28 | Aquestive Therapeutics, Inc. | Dual lane coating |
US9756874B2 (en) | 2011-07-11 | 2017-09-12 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
WO2015112603A1 (en) | 2014-01-21 | 2015-07-30 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
CA2842952C (en) | 2011-07-21 | 2019-01-08 | Proteus Digital Health, Inc. | Mobile communication device, system, and method |
US9235683B2 (en) | 2011-11-09 | 2016-01-12 | Proteus Digital Health, Inc. | Apparatus, system, and method for managing adherence to a regimen |
WO2013176774A1 (en) | 2012-05-25 | 2013-11-28 | Arizona Board Of Regents | Microbiome markers and therapies for autism spectrum disorders |
AU2013271336B2 (en) | 2012-06-04 | 2017-11-30 | Centre For Digestive Diseases | Compositions and methods for treating Crohn's Disease and related conditions and infections |
KR20150038038A (ko) | 2012-07-23 | 2015-04-08 | 프로테우스 디지털 헬스, 인코포레이티드 | 섭취 가능한 부품을 포함하는 섭취 가능한 이벤트 마커를 제조하기 위한 기술 |
EP2877163B1 (en) | 2012-07-27 | 2019-03-20 | Redhill Biopharma Ltd. | Formulations and methods of manufacturing formulations for use in colonic evacuation |
MX340182B (es) | 2012-10-18 | 2016-06-28 | Proteus Digital Health Inc | Aparato, sistema, y metodo para optimizar adaptativamente la disipacion de energia y la energia de difusion en una fuente de energia para un dispositivo de comunicacion. |
JP2016508529A (ja) | 2013-01-29 | 2016-03-22 | プロテウス デジタル ヘルス, インコーポレイテッド | 高度に膨張可能なポリマーフィルムおよびこれを含む組成物 |
US9636305B2 (en) * | 2013-03-14 | 2017-05-02 | Redhill Biopharma Ltd. | Antiemetic extended release solid dosage forms |
WO2014144738A1 (en) | 2013-03-15 | 2014-09-18 | Proteus Digital Health, Inc. | Metal detector apparatus, system, and method |
EP2991649B1 (en) | 2013-04-30 | 2020-06-03 | Thomas Julius Borody | Compositions for treating obsessive-compulsive disorder |
EP3968263A1 (en) | 2013-06-04 | 2022-03-16 | Otsuka Pharmaceutical Co., Ltd. | System, apparatus and methods for data collection and assessing outcomes |
US9796576B2 (en) | 2013-08-30 | 2017-10-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
WO2015028670A2 (en) * | 2013-09-01 | 2015-03-05 | Danmarks Tekniske Universitet | Method for the fabrication of multi-layered micro-containers for drug delivery |
CN105579033A (zh) * | 2013-09-27 | 2016-05-11 | 强生消费者公司 | 压制包衣的脉动释放组合物 |
US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
US9675588B2 (en) | 2014-03-11 | 2017-06-13 | Redhill Biopharma Ltd. | Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms |
WO2015187746A1 (en) | 2014-06-02 | 2015-12-10 | Teva Pharmaceutical Industries Ltd. | Expandable gastroretentive dosage form |
BR112017024264B1 (pt) | 2015-05-14 | 2022-07-12 | Crestovo Holdings Llc | Composições para transplante de flora fecal e métodos de preparação e utilização das mesmas, e dispositivos para sua administração |
DK3297644T3 (da) | 2015-05-22 | 2022-04-11 | Univ Arizona State | Fremgangsmåder til behandling af autismespektrumforstyrrelse og forbundne symptomer |
US11051543B2 (en) | 2015-07-21 | 2021-07-06 | Otsuka Pharmaceutical Co. Ltd. | Alginate on adhesive bilayer laminate film |
WO2017053327A1 (en) | 2015-09-24 | 2017-03-30 | San Diego State University (Sdsu) Foundation , Dba San Diego State University Research Foundation | Antibacterial and protective bacteriophage formulations and methods for making and using them |
US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
KR20190005199A (ko) | 2016-05-05 | 2019-01-15 | 어퀘스티브 테라퓨틱스, 아이엔씨. | 강화된 전달 에프네프린 조성물 |
US20170360848A1 (en) | 2016-06-15 | 2017-12-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods for treating autism spectrum disorder and associated symptoms |
US10849936B2 (en) | 2016-07-01 | 2020-12-01 | Regents Of The University Of Minnesota | Compositions and methods for C. difficile treatment |
CN109843149B (zh) | 2016-07-22 | 2020-07-07 | 普罗秋斯数字健康公司 | 可摄入事件标记的电磁感测和检测 |
US20180036352A1 (en) | 2016-08-03 | 2018-02-08 | Crestovo Holdings Llc | Methods for treating ulcerative colitis |
EA036784B1 (ru) | 2016-08-18 | 2020-12-21 | Илько Илач Санайи Ве Тиджарет Аноним Ширкети | Таблетированный состав с улучшенным профилем растворения для лечения болезни паркинсона |
US10092601B2 (en) | 2016-10-11 | 2018-10-09 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
WO2018071537A1 (en) | 2016-10-11 | 2018-04-19 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
WO2018071536A1 (en) | 2016-10-11 | 2018-04-19 | Crestovo Holdings Llc | Compositions and methods for treating primary sclerosing cholangitis and related disorders |
EP3531901A4 (en) | 2016-10-26 | 2021-01-27 | Proteus Digital Health, Inc. | CAPSULE PREPARATION PROCESSES WITH INGERABLE EVENT MARKERS |
JP7071748B2 (ja) | 2016-12-02 | 2022-05-19 | クレキシオ バイオサイエンシーズ エルティーディー. | 胃内滞留システム |
CA3058818A1 (en) | 2017-04-05 | 2018-10-11 | Crestovo Holdings Llc | Compositions and methods for treating parkinson's disease (pd) and related disorders |
WO2018187464A1 (en) | 2017-04-05 | 2018-10-11 | Crestovo Holdings Llc | Compositions and methods for treating diverticulitis and related disorders |
CA3064773A1 (en) | 2017-05-26 | 2018-11-29 | Crestovo Holdings Llc | Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same |
JP2020530494A (ja) | 2017-08-07 | 2020-10-22 | フィンチ セラピューティクス、インコーポレイテッド. | 健康な腸バリアを維持及び回復するための組成物及び方法 |
US11547839B2 (en) | 2017-12-04 | 2023-01-10 | Clexio Biosciences Ltd. | Long acting gastric residence system |
US20190247331A1 (en) | 2018-02-15 | 2019-08-15 | Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság | Composition and method for treating neurological disease |
US10213394B1 (en) | 2018-02-15 | 2019-02-26 | Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság | Composition and method for treating neurological disease |
US10213393B1 (en) | 2018-02-15 | 2019-02-26 | Osmotica Kereskedelmi és Szolgáltató Korlátolt Feleõsségû Társaság | Composition and method for treating neurological disease |
US11166990B2 (en) | 2018-07-13 | 2021-11-09 | Finch Therapeutics Holdings Llc | Methods and compositions for treating ulcerative colitis |
KR20210065969A (ko) | 2018-09-27 | 2021-06-04 | 핀치 테라퓨틱스 홀딩스 엘엘씨 | 간질 및 관련 장애를 치료하기 위한 조성물 및 방법 |
WO2021016710A1 (en) * | 2019-07-30 | 2021-02-04 | Tassili Life Sciences, Corp. | Controlled release formulations of multiple active pharmaceutical agents, and psilocybe-derived agents in combination with cannabis-derived agents and methods for their use |
US20220175662A1 (en) * | 2020-11-14 | 2022-06-09 | Regents Of The University Of Minnesota | Sustained release device for treatment of parkinson's disease and other disorders |
EP4337169A1 (en) * | 2021-05-11 | 2024-03-20 | Cingulate Therapeutics LLC | Trimodal, precision-timed pulsatile release tablet |
WO2023158694A1 (en) * | 2022-02-16 | 2023-08-24 | Cingulate Therapeutics LLC | Trimodal, precision-timed release tablet |
Family Cites Families (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08211279A (ja) | 1995-02-07 | 1996-08-20 | Sanyo Electric Co Ltd | 太陽光採光装置における採光プリズムの保持装置 |
US2560649A (en) | 1948-07-19 | 1951-07-17 | William H D Hornaday | Disposable cleaner device |
US3634260A (en) | 1962-02-09 | 1972-01-11 | Colgate Palmolive Co | Bleaching packets |
US3346502A (en) | 1962-02-09 | 1967-10-10 | Colgate Palmolive Co | Bleaching composition |
US3300546A (en) | 1965-10-05 | 1967-01-24 | American Cyanamid Co | Water soluble envelope prepared from a graft polymer of alkyl acrylate on a polyvinyl alcohol/polyvinyl acetate co-polymer |
CA813298A (en) | 1966-07-08 | 1969-05-20 | W. Gray Frederick | Bleaching packets |
US3556765A (en) | 1967-08-08 | 1971-01-19 | Encap Products Co | Liquid soluble packet |
US3877928A (en) | 1967-08-08 | 1975-04-15 | Walter A Houston | Liquid soluble packet |
FR1588744A (pt) | 1967-10-31 | 1970-04-17 | ||
US3534851A (en) | 1968-03-18 | 1970-10-20 | Us Health Education & Welfare | Urine preservation package |
US3525426A (en) | 1968-08-21 | 1970-08-25 | James P Miller | Drain cleaning cartridge |
US3671439A (en) | 1969-07-22 | 1972-06-20 | American Home Prod | Oxygen bleach-activator systems stabilized with puffed borax |
US3857195A (en) | 1973-10-01 | 1974-12-31 | A Johnson | Mulch packet |
US4367156A (en) | 1980-07-02 | 1983-01-04 | The Procter & Gamble Company | Bleaching process and compositions |
US4673405A (en) | 1983-03-04 | 1987-06-16 | Alza Corporation | Osmotic system with instant drug availability |
US4576604A (en) | 1983-03-04 | 1986-03-18 | Alza Corporation | Osmotic system with instant drug availability |
US4627850A (en) * | 1983-11-02 | 1986-12-09 | Alza Corporation | Osmotic capsule |
JPS62103012A (ja) | 1985-10-23 | 1987-05-13 | Eisai Co Ltd | 多重顆粒 |
IT1188212B (it) | 1985-12-20 | 1988-01-07 | Paolo Colombo | Sistema per il rilascio a velocita' controllata di sostanze attive |
US4851394A (en) | 1986-12-30 | 1989-07-25 | Uni Colloid Kabushiki Kaisha | Glucomannan/polyhydric alcohol composition and film prepared therefrom |
US4801461A (en) | 1987-01-28 | 1989-01-31 | Alza Corporation | Pseudoephedrine dosage form |
US4810502A (en) | 1987-02-27 | 1989-03-07 | Alza Corporation | Pseudoephedrine brompheniramine therapy |
US4765916A (en) | 1987-03-24 | 1988-08-23 | The Clorox Company | Polymer film composition for rinse release of wash additives |
US4747976A (en) | 1987-05-14 | 1988-05-31 | The Clorox Company | PVA films with nonhydrolyzable anionic comonomers for packaging detergents |
US4999226A (en) | 1988-06-01 | 1991-03-12 | Merrell Dow Pharmaceuticals Inc. | Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination |
JPH03148215A (ja) | 1989-11-01 | 1991-06-25 | Nippon Shinyaku Co Ltd | 積層製剤 |
IE66933B1 (en) | 1990-01-15 | 1996-02-07 | Elan Corp Plc | Controlled absorption naproxen formulation for once-daily administration |
US5221536A (en) | 1990-05-07 | 1993-06-22 | Alza Corporation | Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
US5190763A (en) | 1990-05-07 | 1993-03-02 | Alza Corporation | Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
US5192550A (en) | 1990-05-07 | 1993-03-09 | Alza Corporation | Dosage form for treating central nervous system disorders |
US5057321A (en) | 1990-06-13 | 1991-10-15 | Alza Corporation | Dosage form comprising drug and maltodextrin |
US5128145A (en) | 1990-06-13 | 1992-07-07 | Alza Corporation | Dosage form for Parkinson's disease, spasticity and muscle spasms |
DK0542364T3 (da) | 1991-11-13 | 1996-03-11 | Glaxo Canada | Anordning til reguleret frigivelse |
US5162117A (en) | 1991-11-22 | 1992-11-10 | Schering Corporation | Controlled release flutamide composition |
US5270054A (en) | 1992-09-03 | 1993-12-14 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Cosmetic capsules |
IT1255522B (it) | 1992-09-24 | 1995-11-09 | Ubaldo Conte | Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita' |
DE69425453T2 (de) | 1993-04-23 | 2001-04-12 | Novartis Ag | Wirkstoffabgabevorrichtung mit gesteuerter Freigabe |
IT1264696B1 (it) | 1993-07-09 | 1996-10-04 | Applied Pharma Res | Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata |
US6183778B1 (en) | 1993-09-21 | 2001-02-06 | Jagotec Ag | Pharmaceutical tablet capable of liberating one or more drugs at different release rates |
US5395626A (en) | 1994-03-23 | 1995-03-07 | Ortho Pharmaceutical Corporation | Multilayered controlled release pharmaceutical dosage form |
US5558879A (en) | 1995-04-28 | 1996-09-24 | Andrx Pharmaceuticals, Inc. | Controlled release formulation for water soluble drugs in which a passageway is formed in situ |
IT1282576B1 (it) | 1996-02-06 | 1998-03-31 | Jagotec Ag | Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili |
JP4263776B2 (ja) | 1996-08-09 | 2009-05-13 | 杏林製薬株式会社 | イブジラストの徐放化経口錠剤およびその製造方法 |
US6919373B1 (en) | 1996-11-12 | 2005-07-19 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
US6756056B2 (en) | 1997-04-08 | 2004-06-29 | Alan A. Rubin | Treatment of Parkinson's disease and related disorders by novel formulations of the combination carbidopa-levodopa |
BRPI9802144B1 (pt) | 1997-05-30 | 2017-03-28 | Ezequiel Mayorga Jorge | dispositivo osmótico multicapa aperfeiçoado |
IT1295271B1 (it) * | 1997-10-03 | 1999-05-04 | Chiesi Farma Spa | Monolita contenente uno o piu'farmaci costituito da tre strati a meccanismo di rilascio differenziato |
FR2772615B1 (fr) | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
DE69919155T2 (de) | 1998-05-15 | 2005-08-04 | Chugai Seiyaku K.K. | Formulierungen zur mehrfachfreisetzung |
US5968554A (en) | 1998-07-07 | 1999-10-19 | Cascade Development, Inc. A Subsidiary Of Cardinal Health, Inc. | Sustained release pharmaceutical preparation |
WO2000015197A1 (en) | 1998-09-14 | 2000-03-23 | Rubin Alan A | Improvement in treatment of parkinson's disease and related disorders by novel formulations of the combination carbidopa-levodopa |
US6340476B1 (en) * | 1999-04-06 | 2002-01-22 | Armaquest, Inc. | Pharmaceutical dosage form for pulsatile delivery of methylphenidate |
US20030170181A1 (en) | 1999-04-06 | 2003-09-11 | Midha Kamal K. | Method for preventing abuse of methylphenidate |
US6294199B1 (en) | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
US6613357B2 (en) | 2000-01-13 | 2003-09-02 | Osmotica Corp. | Osmotic device containing pseudoephedrine and an H1 antagonist |
US6599532B2 (en) | 2000-01-13 | 2003-07-29 | Osmotica Corp. | Osmotic device containing alprazolam and an antipsychotic agent |
US6572890B2 (en) | 2000-01-13 | 2003-06-03 | Osmotica Corp. | Osmotic device containing venlafaxine and an anti-psychotic agent |
US6521255B2 (en) | 2000-01-13 | 2003-02-18 | Osmotica Corp. | Osmotic device containing ranitidine and a prokinetic agent |
US6569456B2 (en) | 2000-01-13 | 2003-05-27 | Osmotica Corp. | Osmotic device containing diltiazem and an ACE inhibitor or diuretic |
WO2002030392A2 (en) | 2000-10-12 | 2002-04-18 | Beecham Pharmaceuticals (Pte) Limited | Formulation containing amoxicillin |
US20030143272A1 (en) * | 2001-03-14 | 2003-07-31 | Waterman Kenneth C. | Pharmaceutical tablet and process for making thereof |
US20030035839A1 (en) | 2001-05-15 | 2003-02-20 | Peirce Management, Llc | Pharmaceutical composition for both intraoral and oral administration |
US6605302B2 (en) | 2001-07-17 | 2003-08-12 | Osmotica Corp. | Drug delivery device containing oseltamivir and an H1 antagonist |
US20030092724A1 (en) | 2001-09-18 | 2003-05-15 | Huaihung Kao | Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic |
US20030224045A1 (en) | 2002-05-29 | 2003-12-04 | Chien-Hsuan Han | Combination immediate release sustained release levodopa/carbidopa dosage forms |
US7094427B2 (en) | 2002-05-29 | 2006-08-22 | Impax Laboratories, Inc. | Combination immediate release controlled release levodopa/carbidopa dosage forms |
US20040166159A1 (en) | 2002-05-29 | 2004-08-26 | Chien-Hsuan Han | Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa |
WO2003101431A1 (en) | 2002-06-04 | 2003-12-11 | J.B. Chemicals & Pharmaceuticals Ltd. | Pharmaceutical composition for controlled drug delivery system |
WO2003105809A1 (en) | 2002-06-17 | 2003-12-24 | Themis Laboratories Private Limited | Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them |
US20040115265A1 (en) | 2002-12-11 | 2004-06-17 | Loutfy Benkerrour | Multilayered tablet containing pravastatin and aspirin and method |
US20040253311A1 (en) | 2002-12-18 | 2004-12-16 | Roger Berlin | Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines |
TWI313598B (en) | 2002-12-18 | 2009-08-21 | Wyeth Corp | Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines |
US20070077301A1 (en) | 2002-12-23 | 2007-04-05 | Meyer Glenn A | Venlafaxine osmotic device formulation |
US8293799B2 (en) | 2003-12-29 | 2012-10-23 | Osmotica Keresleedelmo és Szolgáltató KFT | Osmotic device containing a venlafaxine salt and a salt having an ion in common |
AU2003302147A1 (en) | 2002-12-23 | 2004-07-14 | Osmotica Costa Rica Sociedad Anonima | Delivery device containing venlafaxine and memantine and use method thereof |
WO2004064815A1 (en) | 2003-01-21 | 2004-08-05 | Smartrix Technologies Inc. | Oral dosage formulation |
AR043467A1 (es) | 2003-03-05 | 2005-07-27 | Osmotica Argentina S A | Combinacion de drogas para la disfuncion motora en la enfermedad de parkinson |
WO2004087095A2 (es) | 2003-03-31 | 2004-10-14 | Osmotica Costa Rica, Sociedad Anonima | Dispositivo osmótico que contiene zafirlukast y un antagonista h1 |
CA2635313C (en) | 2005-12-29 | 2013-12-31 | Osmotica Corp. | Triple combination release multi-layered tablet |
-
2006
- 2006-12-20 CA CA2635313A patent/CA2635313C/en not_active Expired - Fee Related
- 2006-12-20 DE DE602006018529T patent/DE602006018529D1/de active Active
- 2006-12-20 AT AT06848803T patent/ATE489079T1/de not_active IP Right Cessation
- 2006-12-20 BR BRPI0620863A patent/BRPI0620863A8/pt not_active Application Discontinuation
- 2006-12-20 WO PCT/CR2006/000008 patent/WO2007073702A2/es active Application Filing
- 2006-12-20 EP EP06848803A patent/EP1970055B1/en not_active Not-in-force
- 2006-12-21 AR ARP060105708A patent/AR058604A1/es not_active Application Discontinuation
-
2008
- 2008-06-18 US US12/141,677 patent/US8685451B2/en active Active
-
2014
- 2014-02-24 US US14/188,150 patent/US9833412B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
BRPI0620863A2 (pt) | 2011-11-29 |
EP1970055B1 (en) | 2010-11-24 |
US20140302141A1 (en) | 2014-10-09 |
CA2635313C (en) | 2013-12-31 |
CA2635313A1 (en) | 2007-07-05 |
ATE489079T1 (de) | 2010-12-15 |
DE602006018529D1 (de) | 2011-01-05 |
US20080299197A1 (en) | 2008-12-04 |
WO2007073702A2 (es) | 2007-07-05 |
US9833412B2 (en) | 2017-12-05 |
EP1970055A4 (en) | 2010-04-28 |
US8685451B2 (en) | 2014-04-01 |
EP1970055A2 (en) | 2008-09-17 |
WO2007073702A3 (es) | 2007-09-13 |
AR058604A1 (es) | 2008-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0620863A8 (pt) | comprimido em camadas com combinação de liberação tripla | |
ECSP077999A (es) | Formulaciones de una sal de bupropion de liberación modificada | |
BRPI0513909A (pt) | comprimido farmacêutico de camada múltipla para a liberação controlada de ingredientes ativos com solubilidade altamente dependente do ph | |
NO20084065L (no) | Hurtig frigivelses paracetamol tabletter | |
CL2007003797A1 (es) | Compuestos derivados de pirrolo piridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la enfermedad de alzheimer, parkinson, cancer, entre otras enfermedades. | |
BRPI0606883A2 (pt) | composição farmacêutica para administração oral, método para preparar um tablete, e, forma de dosagem sólida única | |
ES2531118T3 (es) | Composición farmacéutica que comprende lacosamida y levetiracetamo para uso en el tratamiento de la epilepsia | |
CL2007002526A1 (es) | Un medicamento que comprende, separado o juntos: a) una sal de glicopirronio; b) un agonista del adreno-receptor beta-2 seleccionado de salmeterol y formoterol; y c) un corticosteroide; kit farmaceutico; y uso en el tratamiento de una enfermedad infl | |
MX2009000730A (es) | Liberacion controlada de formulaciones y metodos asociados. | |
CO6400186A2 (es) | Tabletas de acetato de ulipristal | |
ATE509636T1 (de) | Kombination aus einem cholinesterase-hemmer und einer verbindung mit 5-ht6-rezeptor-affinität | |
BR9814345A (pt) | Comprimido para liberação imediata e prolongada de uma ou mais substâncias ativas | |
BRPI0715247B8 (pt) | forma farmacêutica com camada de separação de múltiplas camadas, seu uso e seu processo de produção | |
CL2007001724A1 (es) | Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1 | |
BRPI0518266B8 (pt) | medicamento oral de liberação modificada de pelo menos um princípio ativo sob a forma multimicrocapsular | |
MX2009004874A (es) | Formulaciones farmaceuticas estratificadas que comprenden una capa intermediaria que se disuelve rapidamente. | |
CO5900010A1 (es) | Composicion farmaceutica estable de glimepirida con liberacion inmediata y metformina con liberacion prolongada | |
BRPI0513598A (pt) | formas de dosagem em comprimidos revestidos de liberação entérica | |
AR037407A1 (es) | Composiciones farmaceuticas para el tratamiento de la diabetes mellitus de tipo ii | |
BRPI0717369A2 (pt) | Composto, medicamento, composição farmacêutica que o contém e uso do composto. | |
NO20082047L (no) | Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme | |
BRPI0705932A (pt) | distribuidor de produtos de cuidados pessoais | |
CL2007002875A1 (es) | Composicion farmaceutica recubierta por una pelicula que comprende capecitabina y al menos un disgregante, util en el tratamiento del cancer para pacientes que tienen dificultad para tragar las formas de dosificacion solidas orales. | |
HN2003000183A (es) | Difenilazetidinonas sustituidas en anillo procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso. | |
AR063152A1 (es) | Farmaco combinado |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: OSMOTICA KERESKEDELMI ES SZOLGALGATO KFT (HU) Free format text: TRANSFERIDO DE: OSMOTICA CORP. |
|
B25G | Requested change of headquarter approved |
Owner name: OSMOTICA KERESKEDELMI ES SZOLGALGATO KFT (HU) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |